POM Wonderful LLC   Report issue

For profit Phase 3
Founded: Los Angeles CA United States (1979)
Status: Left NME R&D (2017)

Organization Overview

First Clinical Trial
2003
NCT00728299
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

POM Wonderful LLC | Roll International Corporation

Active Ingredients

Drugs in Phase 3 Trials (1)

pomegranate (16 trials)

Drugs in Other Trials (1)

ellagic acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiomyopathies (Phase 2)

Common Cold (Phase 3)

Erectile Dysfunction (Phase 2)

Headache (Phase 3)

Heart Failure (Phase 2)

Infertility (Phase 1)

Infertility, Male (Phase 1)

Influenza, Human (Phase 3)

Prostatic Neoplasms (Phase 2)

Renal Insufficiency (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 17
  • # of Trial APIs: 2